Smith Nephew Company Leadership

SNN Stock  USD 23.84  0.17  0.71%   
Smith Nephew employs about 18.5 K people. The company is managed by 58 executives with a total tenure of roughly 377 years, averaging almost 6.0 years of service per executive, having 318.14 employees per reported executive. Analysis of Smith Nephew's management performance can provide insight into the firm performance.
Roland Diggelmann  CEO
Chief Executive Officer, Executive Director
Namal Nawana  CEO
Chief Executive Officer, Executive Director
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Smith Nephew's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Smith Nephew's future performance. Based on our forecasts, it is anticipated that Smith will maintain a workforce of about 18450 employees by May 2024.
 
Yuan Drop
 
Covid

Smith Nephew's latest congressional trading

Congressional trading in companies like Smith Nephew SNATS, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Smith Nephew by those in governmental positions are based on the same information available to the general public.
2023-07-10Representative Daniel GoldmanDisposed $15K to $50KVerify
2021-02-26Representative Michael T. McCaulAcquired $15K to $50KVerify

Smith Nephew Management Team Effectiveness

The company has Return on Asset of 0.0427 % which means that on every $100 spent on assets, it made $0.0427 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0502 %, implying that it generated $0.0502 on every 100 dollars invested. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Tangible Assets is likely to drop to 0.04. In addition to that, Return On Capital Employed is likely to drop to 0.12. At this time, Smith Nephew's Total Assets are very stable compared to the past year. As of the 19th of April 2024, Non Current Assets Total is likely to grow to about 6.3 B, while Other Current Assets are likely to drop about 87.4 M.
As of the 19th of April 2024, Common Stock Shares Outstanding is likely to grow to about 551.8 M. Also, Net Income Applicable To Common Shares is likely to grow to about 499 M

Smith Nephew Workforce Comparison

Smith Nephew SNATS is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 226,310. Smith Nephew holds roughly 18,452 in number of employees claiming about 8% of equities under Health Care industry.

Smith Nephew Profit Margins

The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.580.667
Fairly Down
Slightly volatile
Net Profit Margin0.0450.0474
Notably Down
Slightly volatile
Operating Profit Margin0.190.1689
Moderately Up
Slightly volatile
Pretax Profit Margin0.05480.0577
Notably Down
Slightly volatile
Return On Assets0.0250.0263
Notably Down
Slightly volatile
Return On Equity0.04790.0504
Notably Down
Slightly volatile

Smith Nephew SNATS Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Smith Nephew SNATS Price Series Summation is a cross summation of Smith Nephew price series and its benchmark/peer.

Smith Nephew Notable Stakeholders

A Smith Nephew stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Smith Nephew often face trade-offs trying to please all of them. Smith Nephew's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Smith Nephew's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Roland DiggelmannChief Executive Officer, Executive DirectorProfile
Namal NawanaChief Executive Officer, Executive DirectorProfile
Deepak NathChief Executive OfficerProfile
Olivier BohuonCEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance CommitteeProfile
Roberto QuartaNon-Executive Independent Chairman of the BoardProfile
Simon FraserPresident - Advanced Wound Management and Global Commercial OperationsProfile
Massimiliano ColellaPresident Europe - Middle East and AfricaProfile
Glenn WarnerPresident - Advanced Wound ManagementProfile
Paul ConnollyPresident OperationsProfile
Phil CowdyExecutive Vice President of Business Development & Corporate AffairsProfile
Mark GladwellPresident - Global Operations and Global Business ServicesProfile
Vasant PadmanabhanPresident - Research & DevelopmentProfile
Diogo MoreiraRatoPresident - Europe and CanadaProfile
Skip KiilPresident - OrthopedicsProfile
Matthew StoberPresident - Global OperationsProfile
Rodrigo BianchiInterim President - Asia PacificProfile
Bradley CannonPresident OrthopaedicsProfile
Michael FrazzettePresident - Advanced Surgical DevicesProfile
Gordon HowePresident of Global OperationsProfile
Brad CannonPresident - Sports Medicine & ENTProfile
Ian MellingInterim Chief Financial OfficerProfile
Michael FriedmanNon-Executive Independent DirectorProfile
Vinita BaliNon-Executive Independent DirectorProfile
John RogersCFO DirectorProfile
Graham BakerChief Financial Officer, Executive DirectorProfile
Rick MedlockNon-Executive Independent DirectorProfile
Angie RisleyNon-Executive Independent DirectorProfile
John MaNon-Executive Independent DirectorProfile
Joseph PapaNon-Executive Independent DirectorProfile
Ian BarlowNon-Executive Independent DirectorProfile
Bob WhiteNon-Executive Independent DirectorProfile
Erik EngstromNon-Executive Independent DirectorProfile
Marc OwenNon-Executive Independent DirectorProfile
AnneFrancoise NesmesChief Financial Officer, Executive DirectorProfile
Brian LarcombeSenior Independent Non-Executive DirectorProfile
Katarzyna MazurHofsaessNon-Executive Independent DirectorProfile
Julie BrownCFO, Director and Member of Disclosures CommitteeProfile
Robin FreestoneSenior Non-Executive Independent DirectorProfile
Virginia BottomleyNon-Executive Independent DirectorProfile
Ingeborg OieVP, Investor RelationsProfile
Helen BarracloughCompany CounselProfile
Gunthorp OieIR Contact OfficerProfile
Helen MayeChief Human Resources OfficerProfile
Cathy ORourkeChief Legal and Compliance OfficerProfile
Joe MetzgerSenior CommunicationsProfile
Susan SwabeyCompany SecretaryProfile
Melissa GuerdanChief Quality and Regulatory Affairs OfficerProfile
Philip CowdyChief OfficerProfile
Alison ParkesChief OfficerProfile
Elga LohlerChief Human Resource OfficerProfile
Cyrille PetitChief Corporate Development OfficerProfile
Peter CoenenPresident - EMEA RegionProfile
Myra EskesPresident - Asia PacificProfile
Andrew SwiftVice RelationsProfile
Steve KaneGlobal USProfile
John CampoChief Legal OfficerProfile
Jo HallasNon-Executive DirectorProfile
Catheryn ORourkeChief Legal and Compliance OfficerProfile

About Smith Nephew Management Performance

The success or failure of an entity such as Smith Nephew SNATS often depends on how effective the management is. Smith Nephew management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Smith management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Smith management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.04  0.04 
Return On Capital Employed 0.12  0.12 
Return On Assets 0.03  0.03 
Return On Equity 0.05  0.05 
The data published in Smith Nephew's official financial statements usually reflect Smith Nephew's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Smith Nephew SNATS. For example, before you start analyzing numbers published by Smith accountants, it's critical to develop an understanding of what Smith Nephew's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Smith Nephew's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Smith Nephew's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Smith Nephew's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Smith Nephew SNATS. Please utilize our Beneish M Score to check the likelihood of Smith Nephew's management manipulating its earnings.

Smith Nephew Workforce Analysis

Traditionally, organizations such as Smith Nephew use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Smith Nephew within its industry.

Smith Nephew Manpower Efficiency

Return on Smith Nephew Manpower

Revenue Per Employee300.7K
Revenue Per Executive95.7M
Net Income Per Employee14.3K
Net Income Per Executive4.5M
Working Capital Per Employee95.3K
Working Capital Per Executive30.3M
When determining whether Smith Nephew SNATS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Smith Nephew's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Smith Nephew Snats Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Smith Nephew Snats Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Smith Stock analysis

When running Smith Nephew's price analysis, check to measure Smith Nephew's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Smith Nephew is operating at the current time. Most of Smith Nephew's value examination focuses on studying past and present price action to predict the probability of Smith Nephew's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Smith Nephew's price. Additionally, you may evaluate how the addition of Smith Nephew to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Is Smith Nephew's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.983
Dividend Share
0.375
Earnings Share
0.6
Revenue Per Share
2.5484
Quarterly Revenue Growth
0.076
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.